EXAGEN INC (XGN) Forecast, Price Target & Analyst Ratings

NASDAQ:XGN • US30068X1037

Current stock price

2.68 USD
-0.11 (-3.94%)
At close:
2.68 USD
0 (0%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for EXAGEN INC (XGN).

Forecast Snapshot

Consensus Price Target

Price Target
$10.03
+ 274.25% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 4, 2026
Period
Q1 / 2026
EPS Estimate
-$0.23
Revenue Estimate
16.682M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
83.33%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$10.03
Upside
+ 274.25%
From current price of $2.68 to mean target of $10.03, Based on 12 analyst forecasts
Low
$8.08
Median
$10.20
High
$12.60

Price Target Revisions

1 Month
-5.38%
3 Months
-18.52%

Price Target Summary

12 Wall Street analysts provided a forecast for the next 12 months for XGN. The average price target is 10.03 USD. This implies a price increase of 274.25% is expected in the next year compared to the current price of 2.68.
The average price target has been revised downward by 18.52% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

XGN Current Analyst RatingXGN Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6

Analyst Ratings History

XGN Historical Analyst RatingsXGN Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
83.33%
XGN was analyzed by 12 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about XGN.
In the previous month the buy percentage consensus was at a similar level.
XGN was analyzed by 12 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-11KeybancMaintains Overweight -> Overweight
2026-03-11Canaccord GenuityMaintains Buy -> Buy
2026-03-11Craig-HallumMaintains Buy -> Buy
2026-03-10BTIGMaintains Buy -> Buy
2026-02-24TD CowenMaintains Buy -> Buy
2026-02-17BTIGMaintains Buy -> Buy
2026-01-30B. Riley SecuritiesReiterate Buy -> Buy
2025-11-10BTIGMaintains Buy -> Buy
2025-11-05B. Riley SecuritiesReiterate Buy -> Buy
2025-10-27Canaccord GenuityMaintains Buy -> Buy
2025-10-22BTIGMaintains Buy -> Buy
2025-10-14KeybancMaintains Overweight -> Overweight
2025-09-11B. Riley SecuritiesInitiate Buy
2025-07-30KeybancUpgrade Sector Weight -> Overweight
2025-07-30Canaccord GenuityMaintains Buy -> Buy
2025-07-23Craig-HallumInitiate Buy
2025-05-15Cantor FitzgeraldMaintains Overweight -> Overweight
2025-05-13Canaccord GenuityMaintains Buy -> Buy
2025-01-13Cantor FitzgeraldReiterate Overweight -> Overweight
2025-01-03Canaccord GenuityMaintains Buy -> Buy
2024-05-14Cantor FitzgeraldMaintains Overweight -> Overweight
2023-09-26Cantor FitzgeraldReiterate Overweight -> Overweight
2023-08-22Cantor FitzgeraldReiterate Overweight -> Overweight
2023-05-16Cantor FitzgeraldReiterate Overweight -> Overweight
2023-03-22BTIGMaintains Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 4, 2026
Period
Q1 / 2026
EPS Estimate
-$0.23
Revenue Estimate
16.682M
Revenue Q2Q
7.64%
EPS Q2Q
-16.15%
Number of Analysts
8

Next Earnings Revisions

Revenue (1 Month)
-7.52%
Revenue (3 Months)
-8.97%
EPS (1 Month)
-23.53%
EPS (3 Months)
-29.23%

Next Earnings Summary

XGN is expected to report earnings on 5/4/2026. The consensus EPS estimate for the next earnings is -0.23 USD and the consensus revenue estimate is 16.68M USD.
The next earnings revenue estimate has been revised downward by 8.97% in the past 3 months. Downward revisions are a negative sign and indicate that analysts are more pessimistic about the next earnings compared to 3 months ago.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2032

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
XGN revenue by date.XGN revenue by date.
52.548M
15.34%		55.641M
5.89%		66.575M
19.65%		71.941M
8.06%		81.243M
12.93%		90.597M
11.51%		102.72M
13.38%		109.69M
6.79%		125.95M
14.82%		134.73M
6.97%
EBITDA
YoY % growth
XGN ebitda by date.XGN ebitda by date.
-22.169M
43.13%		-11.912M
46.27%		-11.952M
-0.34%		-2.404M
79.89%		5.42M
325.48%		8.484M
56.53%		12.423M
46.43%		17.978M
44.72%		N/AN/A
EBIT
YoY % growth
XGN ebit by date.XGN ebit by date.
-24.337M
39.97%		-13.636M
43.97%		-14.07M
-3.18%		-12.149M
13.65%		-6.784M
44.16%		-3.131M
53.85%		8.686M
377.42%		11.312M
30.23%		7.171M
-36.61%		8.181M
14.08%
Operating Margin
XGN operating margin by date.XGN operating margin by date.
-46.31%-24.51%-21.13%-16.89%-8.35%-3.46%8.46%10.31%5.69%6.07%
EPS
YoY % growth
XGN eps by date.XGN eps by date.
-1.34
50.00%		-0.83
38.06%		-0.89
-6.75%		-0.48
45.45%		-0.19
60.99%		-0.01
97.32%		0.27
5,500.00%		0.29
7.41%		N/AN/A

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		-0.23
-16.15%		-0.18
-4.44%		-0.17
46.57%		-0.17
17.18%		-0.17
25.00%		-0.12
35.44%		-0.09
43.60%		-0.09
45.12%
Revenue
Q2Q % growth		16.682M
7.64%		18.113M
5.30%		18.651M
8.16%		18.5M
11.24%		18.433M
10.50%		20.099M
10.96%		20.831M
11.69%		20.73M
12.05%
EBITDA
Q2Q % growth		-3.131M
-7.04%		-1.944M
-12.78%		-1.389M
12.22%		-1.555M
45.56%		-2.121M
32.26%		-606K
68.83%		134.663K
109.70%		168.337K
110.82%
EBIT
Q2Q % growth		-4.262M
-26.66%		-3.293M
-25.19%		-2.848M
8.12%		-2.909M
41.53%		-3.232M
24.17%		-1.784M
45.81%		-1.145M
59.81%		-1.145M
60.65%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

XGN Yearly Revenue VS EstimatesXGN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 20M 40M 60M 80M 100M
XGN Yearly EPS VS EstimatesXGN Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -1 -2 -3 -4 -5

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
25.87%
EPS Next 5 Year
18.44%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
10.46%
Revenue Next 5 Year
10.29%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
38.88%
EBIT Next 5 Year
28.02%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

EXAGEN INC / XGN Forecast FAQ

Can you provide the average price target for EXAGEN INC stock?

12 analysts have analysed XGN and the average price target is 10.03 USD. This implies a price increase of 274.25% is expected in the next year compared to the current price of 2.68.

What is the next earnings date for XGN stock?

EXAGEN INC (XGN) will report earnings on 2026-05-04.

What are the consensus estimates for EXAGEN INC (XGN) next earnings?

The consensus EPS estimate for the next earnings of EXAGEN INC (XGN) is -0.23 USD and the consensus revenue estimate is 16.68M USD.

What is the consensus rating for XGN stock?

The consensus rating for EXAGEN INC (XGN) is 83.3333 / 100 . This indicates that analysts generally have a positive outlook on the stock.